On 2025-05-02, Tourmaline Bio, Inc. (TRML) announced earnings per share of $-0.89 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.91.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.94 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-02 | 2025-03-31 | $-0.91 | $-0.89 |
| 2025-03-13 | 2024-12-31 | $-0.91 | $-0.86 |
| 2024-11-07 | 2024-09-30 | $-0.84 | $-0.78 |
| 2024-08-08 | 2024-06-30 | $-0.72 | $-0.68 |
| 2024-05-13 | 2024-03-31 | $-0.68 | $-0.55 |
| 2024-03-19 | 2023-12-31 | $-0.75 | $-0.81 |
| 2023-11-14 | 2023-09-30 | $-0.94 | $-1.64 |
| 2023-08-14 | 2023-06-30 | -- | $-2.00 |
| 2023-05-15 | 2023-03-31 | -- | $-5.40 |
| 2023-03-31 | 2022-12-31 | -- | $-4.40 |
| 2022-11-10 | 2022-09-30 | $-4.20 | $-4.60 |
| 2022-08-15 | 2022-06-30 | $-4.60 | $-4.40 |
| 2022-05-12 | 2022-03-31 | $-3.50 | $-4.50 |
| 2022-03-17 | 2021-12-31 | $-3.50 | $-3.10 |
| 2021-11-12 | 2021-09-30 | $-2.80 | $-3.20 |
| 2021-08-12 | 2021-06-30 | $-2.20 | $-4.10 |
| 2021-06-14 | 2021-03-31 | $-17.90 | $-13.00 |